Literature DB >> 26112332

MiR-22 Suppresses BMP7 in the Development of Cirrhosis.

Dong Ji1, Bing Li, Qing Shao, Fan Li, Zhongbin Li, Guofeng Chen.   

Abstract

BACKGROUND/AIMS: New strategies for the prevention and treatment of cirrhosis are urgently needed for improving therapeutic outcome. A role of microRNAs (miRNAs) in the pathogenesis of cirrhosis has been recently acknowledged, whereas the exact involved miRNAs as well as the associated molecular signaling pathways have not been determined. Specifically, the studies on the relationship between miR-22 and bone morphogenic protein 7 (BMP7) in the development of cirrhosis are lacking.
METHODS: We examined the correlation of the levels of miR-22 and bone morphogenic protein 7 (BMP7) in the liver biopsies from patients with cirrhosis. We examined overexpression or suppression of miR-22 on BMP7 in hepatocytes. We examined the binding of miR-22 to the 3'-UTR of BMP7 mRNA. Finally, in a carbon tetrachloride (CCl4)-induced cirrhosis model in mice, we gave mice adeno-associated viruses carrying antisense of miR-22, and examined its effects on BMP7 levels and the hallmarks of cirrhosis.
RESULTS: The levels of miR-22 and BMP7 in the liver biopsies from patients were strongly and inversely correlated. MiR-22 inhibited BMP7 expression in hepatocytes, through directly binding the 3'-UTR of BMP7 mRNA. Expression of antisense miR-22 significantly attenuated the levels of liver fibrosis, portal hypertension and sodium retention caused by CCl4, possibly through upregulation of BMP7.
CONCLUSIONS: MiR-22 promotes the development of cirrhosis through BMP7 suppression.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26112332     DOI: 10.1159/000430276

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  14 in total

1.  Macrophage autophagy regulated by miR-384-5p-mediated control of Beclin-1 plays a role in the development of atherosclerosis.

Authors:  Beiyun Wang; Yuan Zhong; Dong Huang; Jingbo Li
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

2.  Regulation of activating protein-4-associated metastases of non-small cell lung cancer cells by miR-144.

Authors:  Feng Gao; Tao Wang; Zefeng Zhang; Rui Wang; Yang Guo; Junfeng Liu
Journal:  Tumour Biol       Date:  2015-08-08

3.  Role of CTGF gene promoter methylation in the development of hepatic fibrosis.

Authors:  Cuicui Shi; Guangming Li; Yanyan Tong; Yilin Deng; Jiangao Fan
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

4.  LncRNA Neat1 expedites the progression of liver fibrosis in mice through targeting miR-148a-3p and miR-22-3p to upregulate Cyth3.

Authors:  Wei Huang; Feizhou Huang; Rui Zhang; Hongwu Luo
Journal:  Cell Cycle       Date:  2021-02-08       Impact factor: 4.534

5.  Thy-1 dependent uptake of mesenchymal stem cell-derived extracellular vesicles blocks myofibroblastic differentiation.

Authors:  Tzu-Pin Shentu; Tse-Shun Huang; Mateja Cernelc-Kohan; Joy Chan; Simon S Wong; Celia R Espinoza; Chunting Tan; Irene Gramaglia; Henri van der Heyde; Shu Chien; James S Hagood
Journal:  Sci Rep       Date:  2017-12-22       Impact factor: 4.996

6.  Circulating miR-210 and miR-22 combined with ALT predict the virological response to interferon-alpha therapy of CHB patients.

Authors:  Jin Li; Xiaonan Zhang; Liang Chen; Zhanqing Zhang; Jiming Zhang; Weixia Wang; Min Wu; Bisheng Shi; Xinxin Zhang; Maya Kozlowski; Yunwen Hu; Zhenghong Yuan
Journal:  Sci Rep       Date:  2017-11-15       Impact factor: 4.379

7.  MicroRNA-137 inhibits BMP7 to enhance the epithelial-mesenchymal transition of breast cancer cells.

Authors:  Xuexiang Ying; Yunpo Sun; Pingqing He
Journal:  Oncotarget       Date:  2017-03-14

8.  MicroRNA-22 Promotes Renal Tubulointerstitial Fibrosis by Targeting PTEN and Suppressing Autophagy in Diabetic Nephropathy.

Authors:  Yingying Zhang; Siqi Zhao; Depei Wu; Xingmei Liu; Mingjun Shi; Yuanyuan Wang; Fan Zhang; Jing Ding; Ying Xiao; Bing Guo
Journal:  J Diabetes Res       Date:  2018-04-03       Impact factor: 4.011

9.  MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2.

Authors:  Feng Gao; Hao Wu; Rui Wang; Yang Guo; Zefeng Zhang; Tao Wang; Guoliang Zhang; Changjiang Liu; Junfeng Liu
Journal:  Bioengineered       Date:  2019-12       Impact factor: 3.269

10.  MiR-22 as a metabolic silencer and liver tumor suppressor.

Authors:  Lijun Wang; Yu-Shiuan Wang; Eko Mugiyanto; Wei-Chiao Chang; Yu-Jui Yvonne Wan
Journal:  Liver Res       Date:  2020-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.